
NYSE:CVS
CVS is a major pharmacy benefits manager providing tons of data to large companies like GM. He likes the pharmacy business, because it's much cheaper to go to the pharmacy for a vaccine instead of a hospital. Pharmacy will gain market share. CVS will return to dividend increases after their Aetna acquisition. Trades at 10x earnings. Very well-positioned. This is recession-proof. (Analysts’ price target is $116.70)